Compare
Aethlon Medical Inc vs Biotricity Inc. vs HeartBeam, Inc. vs Bluejay Diagnostics, Inc.
| Latest fiscal year | Aethlon Medical Inc AEMD | Biotricity Inc. BTCY | HeartBeam, Inc. BEATW | Bluejay Diagnostics, Inc. BJDX |
|---|---|---|---|---|
| Year ended | 2026-03-31 | 2026-03-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $16.00M | n/a | n/a |
| Revenue growth (YoY) | n/a | +16.0% | n/a | n/a |
| Gross margin | n/a | 80.9% | n/a | n/a |
| Operating margin | n/a | 10.6% | n/a | n/a |
| Net margin | n/a | -15.0% | n/a | n/a |
| Net income | -$7.15M | -$2.40M | -$21.02M | -$6.85M |
| EPS (Diluted) | -$10.61 | -$0.12 | -$0.62 | -$15.25 |
| Operating cash flow | -$7.00M | -$719.0K | -$13.99M | -$6.05M |
| Free cash flow | -$7.00M | n/a | -$14.59M | -$6.23M |
| Cash & equivalents | $5.03M | $149.8K | $4.38M | $5.16M |
| Total assets | $6.33M | $6.45M | $5.84M | $7.12M |
| Total liabilities | $1.45M | $39.41M | $3.24M | $1.14M |
| Shareholders' equity | $4.89M | -$34.68M | $2.60M | $5.98M |
| Return on year-end equity | -146.4% | n/a | -807.3% | -114.6% |
| Shares outstanding | 1.57M | 28.60M | 26.96M | 604.5K |
Revenue, most recent five fiscal years
| Fiscal year | Aethlon Medical Inc | Biotricity Inc. | HeartBeam, Inc. | Bluejay Diagnostics, Inc. |
|---|---|---|---|---|
| Latest | $0 Ended 2024-03-31 | $16.00M Ended 2026-03-31 | n/a | $249.0K Ended 2022-12-31 |
| 1 year earlier | $574.2K Ended 2023-03-31 | $13.79M Ended 2025-03-31 | n/a | n/a |
| 2 years earlier | $294.2K Ended 2022-03-31 | $12.06M Ended 2024-03-31 | n/a | n/a |
| 3 years earlier | $659.1K Ended 2021-03-31 | $9.64M Ended 2023-03-31 | n/a | n/a |
| 4 years earlier | $650.2K Ended 2020-03-31 | $7.65M Ended 2022-03-31 | n/a | n/a |